Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

3:10 PM - 3:15 PM ET

1043 - The Influence of Cancer Primary Site on Outcomes after Preoperative Radiosurgery for Resected Brain Metastases: A XXX International Multicenter Cohort Study
Speaker: Prabhu, Roshan, MD, MS - Atrium Health Levine Cancer, CHARLOTTE, NC
3:10 PM - 3:15 PM ET

1049 - HERMES: 2 Year Outcomes of Randomized Phase II Trial of 2-Fraction and 5-Fraction MRI-Guided Adaptive Radiotherapy for Prostate Cancer
Speaker: Cooper, Sian, MBBS - Guy's and St. Thomas' NHS Foundation Trust, London, Southwark
3:10 PM - 3:15 PM ET

1055 - A Multicenter, Randomized Controlled Phase III Trial of TPF Induction Chemotherapy vs. PF Adjuvant Chemotherapy Combined with Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: Long-Term Follow-up Analysis
Speaker: Jin, Feng, BS - Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou
3:10 PM - 3:15 PM ET

1061 - Adaptive Radiotherapy in Hypersensitive and High Locoregional Risk Breast Cancer: Preliminary Results of the SAHARA04 Phase II Trial
Speaker: Prunaretty, Jessica - Institut du Cancer de Montpellier, Montpellier
3:10 PM - 3:15 PM ET

1073 - Eliminating Uncertainties in Post-Treatment Breast Cosmesis Evaluation using Vision-Language Artificial Intelligence
Speaker: Park, Sangjoon, MD, PhD - Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul
3:10 PM - 3:20 PM ET

211 - The Prognostic Role of Circulating Tumor DNA In Vulvovaginal Cancers Undergoing Radiotherapy
Speaker: Gui, Bin, MD, MS - Northwell Health, Lake Success, NY
3:10 PM - 3:20 PM ET

216 - Overcoming Myeloid-Driven Resistance of High-Grade Gliomas to CAR T Cell Therapy: Mechanistic Determinants and Therapeutic Targeting
Speaker: Gholamin, Sharareh, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA
3:10 PM - 3:20 PM ET

222 - Outcomes from Phase 2 Trial of Preoperative Image Guided Intensity Modulated Photon Radiation Therapy (IMRT) with Simultaneously Integrated Boost (SIB) to the High-Risk Margin for Retroperitoneal Sarcomas (RPS)
Speaker: Liu, Kevin, MD, DPhil - Brigham and Womens Hospital, Boston, MA
3:15 PM - 3:20 PM ET

1044 - Proton vs. Photon Craniospinal Irradiation for Leptomeningeal Disease: Comparative Clinical Outcomes and Acute Toxicities
Speaker: Hoang, Audi, BS - Tilman J Fertitta Family College of Medicine, Houston, TX
3:15 PM - 3:20 PM ET

1050 - Five-Year Outcomes from a Prospective Trial of MR-Guided SBRT with Focal DIL Boost for Intermediate-Risk Prostate Cancer
Speaker: Goglia, Alexander, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
3:15 PM - 3:20 PM ET

1056 - Evaluating Changes in Tumor Volumes Following Expert Interpretation of Planning Imaging in Head and Neck Cancer Radiotherapy
Speaker: Belliveau, Colin, MD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, QC
3:15 PM - 3:20 PM ET

1062 - Interpretable Artificial Intelligence Decision Support Framework for Online Adaptive Radiotherapy Quality Assurance
Speaker: Winter, Jeff, PhD - Princess Margaret Cancer Centre, Toronto, ON